View Financial HealthPCT 配当と自社株買い配当金 基準チェック /06PCT配当金を支払った記録がありません。主要情報n/a配当利回りn/aバイバック利回り総株主利回りn/a将来の配当利回りn/a配当成長n/a次回配当支払日n/a配当落ち日n/a一株当たり配当金n/a配当性向n/a最近の配当と自社株買いの更新更新なしすべての更新を表示Recent updatesお知らせ • Feb 25Pct Ltd Announces Tests Results for Oklahoma & Grassy Creek Crude with Super Catholyte & Nanogas N2 Infused Super CatholytePCT LTD announced Tests Results For Oklahoma & Grassy Creek Crude With Super Catholyte & Nanogas N2 Infused Super Catholyte. For the 14 day field study (7 days in Oklahoma and 7 days in Grassy Creek), a total of ten tests were run: two Spontaneous Imbibition tests at ambient temperature and eight Spontaneous Imbibition tests at a temperature of 120F. Each plug sample was saturated, using a vacuum or capillary force, with two crude oil to conduct this study. The findings from these studies run in Grassy Creek, were equal to the field study results conducted back in December 2021 at aslightincrease from 14.40% to 15.66%. When assessing the results in Oklahoma, they were much more significant with an increased oil recovery of 49.85%. This is also a reflection of the 34 gravity oil in Oklahoma as opposed to the 15 gravity oil in Grassy Creek. Due to the significant and successful results found in Oklahoma utilizing the new generator, PCT will initiate a final comprehensive field study. It will be conducted for a full week, in mid-March, upon transfer of the new-gen Catholyte generator from Oklahoma to Grassy Creek.お知らせ • May 18PCT Ltd announced delayed 10-Q filingOn 05/17/2021, PCT Ltd announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Apr 02PCT Ltd announced delayed annual 10-K filingOn 03/31/2021, PCT Ltd announced that they will be unable to file their next 10-K by the deadline required by the SEC.お知らせ • Jan 29PCT LTD Announces Significant Progress in Commercializing the Annihilyzer Infection Control System in the United KingdomPCT LTD announced that in conjunction with PCT (Europe) Ltd., their efforts to commercialize its Annihilyzer Infection Control Systems with the United Kingdom’s National Health Service has taken a significant step forward, according to a senior executive of NTH Solutions UK, a subsidiary of North Tees NHS Foundation Trust, who are also PCT Europe’s exclusive trading partner. The Hospital will commence the final evaluation of PCTL’s Annihilyzer® on the live Wards following initial results that provided the evidence needed to allow the Hospital’s Infection Control Director to authorize the final phase of testing. This live study will be fully supported by the Infection Control and Operational Decontamination Cleaning Teams. The final stage of the study will utilize the National Institute of Health Research protocols, which will be clinically sponsored by Teesside University’s Microbiology Department. The 8 fully patient occupied Wards being used for the study have been subject to COVID-19 outbreaks and regular Hospital Associated Infections. The University will assist in the collection of base line and pre-evaluation information collected during and post-evaluation to ensure a broad representation of data, which will be published in support of the system and the HOCl fluids it generates.お知らせ • Dec 19PCT LTD Reports Installations of Annihilyzer® Hospital Equipment and Provides Update on Current Share StructurePCT LTD reported the successful installation of four rack-mounted Annihilyzer® systems in another new NYC hospital through the efforts of the Company’s distributor, ACE Janitorial. In addition, two more Annihilyzer® systems are slated for installation in another NYC hospital at the beginning of 2021. The newly installed Annihilyzer® systems are providing hospitals and the healthcare industry at large with cutting edge disinfecting and decontaminating solutions that combat microbial infection during this global pandemic.お知らせ • Dec 13PCT Ltd Engages Sheldon A. Smith as Interim Chief Financial Officer and Interim Chief Legal CounselPCT LTD announced the engagement of Sheldon A. Smith, Esquire (Certified Public Accountant and Juris Doctorate), as the Company’s Interim CFO and Interim Chief Legal Counsel, beginning on January 1, 2021. PCTL and Smith have executed a contract for interim services for the first quarter of 2021. Mr. Smith will be taking the place of the current CFO Marion Sofield. Ms. Sofield is staying with the Company and will be taking on an important role in the marketing department and overseeing special projects for PCT LTD. In the meantime, she will be working closely with Mr. Smith to assist him in a smooth transition.お知らせ • Oct 29PCT Ltd Executes 1 Million Gallon Minimum Annual Supply AgreementPCT Ltd. announced that it has executed a domestic supply agreement with Maverick Energy Services and Maverick Environmental Solutions of Holdenville, Oklahoma for a minimum of 1,000,000 gallons of PCT Hydrolyte® to be delivered over the next twelve months. An initial order has been fulfilled on this contract.お知らせ • Oct 06PCTL Receives Orders and A Cash Deposit from Its Paradigm Convergence Technologies (Europe) LTDPCTL received orders and a cash deposit from its U.K. partner, Paradigm Convergence Technologies (Europe) LTD. One of the provisions in agreement requires a 50% cash deposit, which it have received.お知らせ • Aug 18PCT Ltd announced delayed 10-Q filingOn 08/17/2020, PCT Ltd announced that they will be unable to file their next 10-Q by the deadline required by the SEC.決済の安定と成長配当データの取得安定した配当: PCTLの 1 株当たり配当が過去に安定していたかどうかを判断するにはデータが不十分です。増加する配当: PCTLの配当金が増加しているかどうかを判断するにはデータが不十分です。配当利回り対市場PCT 配当利回り対市場PCTL 配当利回りは市場と比べてどうか？セグメント配当利回り会社 (PCTL)n/a市場下位25% (US)1.4%市場トップ25% (US)4.2%業界平均 (Chemicals)1.7%アナリスト予想 (PCTL) (最長3年)n/a注目すべき配当: PCTLは最近配当金を報告していないため、配当金支払者の下位 25% に対して同社の配当利回りを評価することはできません。高配当: PCTLは最近配当金を報告していないため、配当金支払者の上位 25% に対して同社の配当利回りを評価することはできません。株主への利益配当収益カバレッジ: PCTLの 配当性向 を計算して配当金の支払いが利益で賄われているかどうかを判断するにはデータが不十分です。株主配当金キャッシュフローカバレッジ: PCTLが配当金を報告していないため、配当金の持続可能性を計算できません。高配当企業の発掘7D1Y7D1Y7D1YUS 市場の強力な配当支払い企業。View Management企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/23 19:06終値2026/05/21 00:00収益2022/09/30年間収益2021/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋PCT Ltd 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
お知らせ • Feb 25Pct Ltd Announces Tests Results for Oklahoma & Grassy Creek Crude with Super Catholyte & Nanogas N2 Infused Super CatholytePCT LTD announced Tests Results For Oklahoma & Grassy Creek Crude With Super Catholyte & Nanogas N2 Infused Super Catholyte. For the 14 day field study (7 days in Oklahoma and 7 days in Grassy Creek), a total of ten tests were run: two Spontaneous Imbibition tests at ambient temperature and eight Spontaneous Imbibition tests at a temperature of 120F. Each plug sample was saturated, using a vacuum or capillary force, with two crude oil to conduct this study. The findings from these studies run in Grassy Creek, were equal to the field study results conducted back in December 2021 at aslightincrease from 14.40% to 15.66%. When assessing the results in Oklahoma, they were much more significant with an increased oil recovery of 49.85%. This is also a reflection of the 34 gravity oil in Oklahoma as opposed to the 15 gravity oil in Grassy Creek. Due to the significant and successful results found in Oklahoma utilizing the new generator, PCT will initiate a final comprehensive field study. It will be conducted for a full week, in mid-March, upon transfer of the new-gen Catholyte generator from Oklahoma to Grassy Creek.
お知らせ • May 18PCT Ltd announced delayed 10-Q filingOn 05/17/2021, PCT Ltd announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Apr 02PCT Ltd announced delayed annual 10-K filingOn 03/31/2021, PCT Ltd announced that they will be unable to file their next 10-K by the deadline required by the SEC.
お知らせ • Jan 29PCT LTD Announces Significant Progress in Commercializing the Annihilyzer Infection Control System in the United KingdomPCT LTD announced that in conjunction with PCT (Europe) Ltd., their efforts to commercialize its Annihilyzer Infection Control Systems with the United Kingdom’s National Health Service has taken a significant step forward, according to a senior executive of NTH Solutions UK, a subsidiary of North Tees NHS Foundation Trust, who are also PCT Europe’s exclusive trading partner. The Hospital will commence the final evaluation of PCTL’s Annihilyzer® on the live Wards following initial results that provided the evidence needed to allow the Hospital’s Infection Control Director to authorize the final phase of testing. This live study will be fully supported by the Infection Control and Operational Decontamination Cleaning Teams. The final stage of the study will utilize the National Institute of Health Research protocols, which will be clinically sponsored by Teesside University’s Microbiology Department. The 8 fully patient occupied Wards being used for the study have been subject to COVID-19 outbreaks and regular Hospital Associated Infections. The University will assist in the collection of base line and pre-evaluation information collected during and post-evaluation to ensure a broad representation of data, which will be published in support of the system and the HOCl fluids it generates.
お知らせ • Dec 19PCT LTD Reports Installations of Annihilyzer® Hospital Equipment and Provides Update on Current Share StructurePCT LTD reported the successful installation of four rack-mounted Annihilyzer® systems in another new NYC hospital through the efforts of the Company’s distributor, ACE Janitorial. In addition, two more Annihilyzer® systems are slated for installation in another NYC hospital at the beginning of 2021. The newly installed Annihilyzer® systems are providing hospitals and the healthcare industry at large with cutting edge disinfecting and decontaminating solutions that combat microbial infection during this global pandemic.
お知らせ • Dec 13PCT Ltd Engages Sheldon A. Smith as Interim Chief Financial Officer and Interim Chief Legal CounselPCT LTD announced the engagement of Sheldon A. Smith, Esquire (Certified Public Accountant and Juris Doctorate), as the Company’s Interim CFO and Interim Chief Legal Counsel, beginning on January 1, 2021. PCTL and Smith have executed a contract for interim services for the first quarter of 2021. Mr. Smith will be taking the place of the current CFO Marion Sofield. Ms. Sofield is staying with the Company and will be taking on an important role in the marketing department and overseeing special projects for PCT LTD. In the meantime, she will be working closely with Mr. Smith to assist him in a smooth transition.
お知らせ • Oct 29PCT Ltd Executes 1 Million Gallon Minimum Annual Supply AgreementPCT Ltd. announced that it has executed a domestic supply agreement with Maverick Energy Services and Maverick Environmental Solutions of Holdenville, Oklahoma for a minimum of 1,000,000 gallons of PCT Hydrolyte® to be delivered over the next twelve months. An initial order has been fulfilled on this contract.
お知らせ • Oct 06PCTL Receives Orders and A Cash Deposit from Its Paradigm Convergence Technologies (Europe) LTDPCTL received orders and a cash deposit from its U.K. partner, Paradigm Convergence Technologies (Europe) LTD. One of the provisions in agreement requires a 50% cash deposit, which it have received.
お知らせ • Aug 18PCT Ltd announced delayed 10-Q filingOn 08/17/2020, PCT Ltd announced that they will be unable to file their next 10-Q by the deadline required by the SEC.